Market Overview

Cantor Fiztgerald Downgrades Obagi Medical Products, Inc. to Hold, Raises PT to $19.75

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for OMPI

DateFirmActionFromTo
Apr 2013Cantor FitzgeraldMaintainsHold
Mar 2013Roth CapitalDowngradesBuyNeutral
Mar 2013Cantor FitzgeraldDowngradesBuyHold

View More Analyst Ratings for OMPI
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (OMPI)